This educational activity with neuroradiology and radiation oncology focuses on contouring PNI for parotid and oral cavity cancers.

This webinar was sponsored by the ROI Juan A. del Regato Fund.

This is a lecture-based educational format designed to update participants on the latest evidence-based practice recommendations for head and neck cancer radiation therapy.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of c

This session will review the latest science in the field of head and neck cancer.

Patients treated for head and neck cancers have a high rate of loco-regional recurrence and metastases. The current standards of care are largely based on institutional data or small multi-institutional retrospective collaborative series.

This session will review the current approaches to managing salivary cancers and the systemic treatment for recurrent or metastatic salivary cancers.

This session will examine the current state of evidence surrounding de-escalation of treatment in patients HPV-associated oropharyngeal cancer.

David Burkett is employed by The Burkett Law Firm and has stock ownership in Abbvie and Eli Lily.

This session reviews head and neck cancer from a patient perspective.